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Scientific publishing in the times of open access
Adriano Aguzzi
Editor in chief, Swiss Medical Weekly / Institute of Neuropathology, University Hospital of Zurich, Switzerland
By enabling readers to respond and interact, the ongoing
evolution of the internet is catalysing a profound trans-
formation of the publishing business. While the end
product of this process is not yet recognisable, its impact is
comparable to that triggered by Johannes Gutenberg’s in-
vention of the movable type – and scientific publishing has
not been spared by these momentous developments. The
push for “Open Access” publications may have captured
the largest mindshare of librarians and policy-makers, yet
other aspects may turn out to become even more important
in the years to come.
The Open Access movement derives its strength from its
unquestionable idealism. Given that the prime purpose of
science is to advance the knowledge of mankind, shouldn’t
all mankind be made privy to such knowledge, directly,
with no strings attached, and – most importantly – without
having to pay for it? The moral justification for Open Ac-
cess becomes all the more compelling when one considers
that most research (including, notably, much of the research
carried out at private companies) is funded by the tax-pay-
ing public. While the big publishing houses have initially
resisted, and often derided, the propositions of the Open
Access movement, the validity of the model is now al-
most universally accepted. The Public Library of Science
(PLoS) [1] publishes a conspicuous fraction of the entire
world’s scientific output, and even big conservative pub-
lishing houses like Elsevier and Nature have started featur-
ing Open Access titles within their journal collections.
What is more rarely discussed, however, is the darker side
of the Open Access model (at least as it is generally prac-
ticed today). You see, Open Access does not magically
make the costs of publishing a journal disappear. What it
does, instead, is to shift the cost of publishing from the
readers to the authors, who are typically requested to pay
a fee for seeing their paper published. In truth, this “dirty
little secret” of Open Access publishing creates a conflict
of interest which is virtually impossible to resolve: the
more scientific papers get published, the higher the rev-
enues of the publisher. Consequently, human nature being
what it is, any fledgling (or struggling) journal may feel
tempted to subordinate the scientific soundness of any sub-
mitted manuscript to the harsh pressure of economic realit-
ies. This conflict of interests is intrinsic to the author-pays
model and, of course, this is the reason why a plethora of
Open Access pseudopublishers have opened shop, whose
business models range from the slightly malodorous to the
blatantly fraudulent. The names of these so-called “scien-
ce publishers” are well known to the scientific community,
whose inboxes are regularly flooded by their email spam
campaigns.
Mind you, none of this should be taken to imply that the
Open Access model is inherently flawed. But how can we
ensure that scientific excellence will always prevail over -
financial considerations? In my view, any remedy must un-
couple the publication of manuscripts from the economic
interests of the publisher. This has sometimes been called
the “Platinum Open Access” model, and relies on sponsors
for bearing the costs of publishing the journal. While phil-
anthropists can also act as sponsors, publications can more
realistically be sponsored by consortia of Universities and
Academies.
By running their own Open Access enterprises, the scientif-
ic enterprises can cut out the middlemen and save costs
– while at the same time enforcing their own standards
of ethics and scientific rigorousness in publications. One
particularly successful example of such a “Platinum Open
Access” Journal is eLife [2], which is supported by the
Wellcome Trust, the Max Planck Society, and the Howard
Hughes Medical Institute.
The Swiss Medical Weekly has pledged to follow the Platin-
um Open Access model. Current sponsors of Swiss Medic-
al Weekly are the Swiss Academy of Medical Sciences and
the Swiss Federation of Medical Doctors. Neither authors
nor readers are requested to pay for publishing and/or en-
joying the papers of the Swiss Medical Weekly. As a result,
the only criteria for the acceptance of a manuscript submit-
ted to the Swiss Medical Weekly are its scientific sound-
ness, its novelty, and its usefulness to the readership. No
other considerations play any role in the editorial decision
process, and – crucially – all financial issues are removed
from the equation.
Another development that is completely changing the land-
scape of scientific publishing is the post-publication review
(PPR), which is bound to upend the process by which sci-
entific reports are judged and rated. For the past century,
we have always operated under the assumption that sci-
entific peer reviewing, which lies at the heart of all reput-
able journals of science, is the worst methodology of sci-
ence publishing – except all the others that have been tried
from time to time (as Churchill might have said).
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Yet the flaws of conventional peer reviewing are glaring.
Any submitted paper will be judged by two to three peers,
each one of whom will unavoidably suffer from his or her
own biases and will be more or less conversant in the area
which is to be judged. As a consequence, the peer review-
ing process can become very arbitrary. Many of us have
experienced that the very same manuscript can be shred-
ded into tiny pieces by Nature, and – upon resubmission –
published by Science without a blink (or vice versa). Until
now, however, it was hard or impossible to envisage a sys-
tem that would do away with these conspicuous flaws of
the peer reviewing system.
PPR is about to change all that. Its premise is that any pub-
lication appearing in an Open Access journal can be scru-
tinised by any reader anywhere in the world – and particu-
larly extraordinary claims may be submitted to extraordin-
arily thorough scrutiny. Web sites such as Pubpeer.com are
dedicated to such post-publication exercises. As a result,
any given paper may no longer be judged by just two or
three peers ante factum, but maybe by thousands of them
post factum. The result is inevitably going to ensure a
much more stringent quality control. An interesting mode
of interactive reviewing was championed by StackOver-
flow [3], a technical web site for software engineers. There,
software snippets, bug reports, questions and answers are
continuously rated by the community – with both posters
and raters gaining reputational points for their activities.
Posts can be upvoted or downvoted, but downvotes cost
points and are therefore used judiciously. The result is a
vibrant, incredibly useful and up-to-date compendium of
computer science, and the biology community would be
well-advised to take note. The Swiss Medical Weekly is
committed to post-publication peer reviewing as a crucial
new tool towards the self-correction of science. In the long
run, I envisage an informal, low-threshold system of dis-
cussion and dialogue in which any paper will be commen-
ted upon by peers similarly to how social media such as
Facebook function.
PPR complements the conventional peer reviewing, but we
do not believe that it makes it disposable. Quite on the con-
trary, we at SMW believe that the referees of scientific pa-
pers should be duly rewarded for their work, which is en-
tirely crucial to the edifice of science.
For this reason, Swiss Medical Weekly intends to pay an ap-
propriate honorarium to its referees. Naturally, it is difficult
to set a specific monetary value for the (invaluable!) ser-
vices of the reviewers, but we strongly feel that we should
not simply expect our referees to work pro bono – and our
gratefulness should extend beyond lip service.
In summary, scientific publishing is entering exciting
times. The impact of technological innovations, spurred by
the “Web 2.0”-style, interactive internet, goes well beyond
increased productivity and is beginning to reshape the very
social fabric of scientific endeavour.
In its ongoing renewal process, the Swiss Medical Weekly
is fully committed to embrace completely these develop-
ments. With the help of its authors and its readership, our
publication strives to become the premier address for inter-
esting and impactful developments in the biomedical scien-
ces.
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